Zynex Gross Margin 2010-2024 | ZYXI
Current and historical gross margin for Zynex (ZYXI) over the last 10 years. The current gross profit margin for Zynex as of September 30, 2024 is %.
| Zynex Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-09-30 | $0.19B | $0.15B | 79.38% |
| 2024-06-30 | $0.19B | $0.15B | 79.38% |
| 2024-03-31 | $0.19B | $0.15B | 79.37% |
| 2023-12-31 | $0.18B | $0.15B | 79.35% |
| 2023-09-30 | $0.19B | $0.15B | 79.57% |
| 2023-06-30 | $0.18B | $0.14B | 79.21% |
| 2023-03-31 | $0.17B | $0.13B | 78.82% |
| 2022-12-31 | $0.16B | $0.13B | 78.62% |
| 2022-09-30 | $0.15B | $0.12B | 79.33% |
| 2022-06-30 | $0.14B | $0.11B | 79.72% |
| 2022-03-31 | $0.14B | $0.11B | 79.56% |
| 2021-12-31 | $0.13B | $0.10B | 79.23% |
| 2021-09-30 | $0.12B | $0.09B | 77.59% |
| 2021-06-30 | $0.10B | $0.08B | 77.23% |
| 2021-03-31 | $0.09B | $0.07B | 77.53% |
| 2020-12-31 | $0.08B | $0.06B | 78.75% |
| 2020-09-30 | $0.07B | $0.05B | 79.41% |
| 2020-06-30 | $0.06B | $0.05B | 80.00% |
| 2020-03-31 | $0.05B | $0.04B | 80.39% |
| 2019-12-31 | $0.05B | $0.04B | 80.00% |
| 2019-09-30 | $0.04B | $0.03B | 85.00% |
| 2019-06-30 | $0.04B | $0.03B | 83.33% |
| 2019-03-31 | $0.03B | $0.03B | 82.35% |
| 2018-12-31 | $0.03B | $0.03B | 78.13% |
| 2018-09-30 | $0.03B | $0.02B | 74.19% |
| 2018-06-30 | $0.03B | $0.02B | 73.33% |
| 2018-03-31 | $0.03B | $0.02B | 74.07% |
| 2017-12-31 | $0.02B | $0.02B | 82.61% |
| 2017-09-30 | $0.02B | $0.02B | 94.44% |
| 2017-06-30 | $0.02B | $0.02B | 100.00% |
| 2017-03-31 | $0.01B | $0.01B | 100.00% |
| 2016-12-31 | $0.01B | $0.01B | 76.92% |
| 2016-09-30 | $0.01B | $0.01B | 46.15% |
| 2016-06-30 | $0.01B | $0.01B | 41.67% |
| 2016-03-31 | $0.01B | $0.01B | 41.67% |
| 2015-12-31 | $0.01B | $0.01B | 58.33% |
| 2015-09-30 | $0.01B | $0.01B | 63.64% |
| 2015-06-30 | $0.01B | $0.01B | 66.67% |
| 2015-03-31 | $0.01B | $0.00B | 40.00% |
| 2014-12-31 | $0.01B | $0.00B | 40.00% |
| 2014-09-30 | $0.01B | $0.00B | 36.36% |
| 2014-06-30 | $0.01B | $0.01B | 41.67% |
| 2014-03-31 | $0.02B | $0.01B | 68.75% |
| 2013-12-31 | $0.02B | $0.01B | 66.67% |
| 2013-09-30 | $0.03B | $0.02B | 72.41% |
| 2013-06-30 | $0.03B | $0.03B | 73.53% |
| 2013-03-31 | $0.04B | $0.03B | 74.36% |
| 2012-12-31 | $0.04B | $0.03B | 77.50% |
| 2012-09-30 | $0.04B | $0.03B | 76.92% |
| 2012-06-30 | $0.04B | $0.03B | 76.32% |
| 2012-03-31 | $0.04B | $0.03B | 77.78% |
| 2011-12-31 | $0.03B | $0.03B | 76.47% |
| 2011-09-30 | $0.03B | $0.02B | 77.42% |
| 2011-06-30 | $0.03B | $0.02B | 75.86% |
| 2011-03-31 | $0.03B | $0.02B | 74.07% |
| 2010-12-31 | $0.03B | $0.02B | 76.00% |
| 2010-09-30 | $0.02B | $0.02B | 78.26% |
| 2010-06-30 | $0.02B | $0.02B | 80.95% |
| 2010-03-31 | $0.02B | $0.02B | 84.21% |
| 2009-12-31 | $0.02B | $0.02B | 88.89% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.245B | $0.184B |
| Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $196.826B | 25.11 |
| Stryker (SYK) | United States | $146.166B | 32.94 |
| Boston Scientific (BSX) | United States | $145.408B | 41.81 |
| EssilorLuxottica (ESLOY) | France | $115.383B | 0.00 |
| Medtronic (MDT) | Ireland | $112.944B | 16.78 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.849B | 0.00 |
| Haleon (HLN) | United Kingdom | $41.827B | 27.18 |
| GE HealthCare Technologies (GEHC) | United States | $38.715B | 20.08 |
| ResMed (RMD) | United States | $35.199B | 28.92 |
| Terumo (TRUMY) | Japan | $27.980B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.250B | 18.56 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.811B | 13.89 |
| Insulet (PODD) | United States | $19.347B | 77.04 |
| Baxter (BAX) | United States | $15.818B | 10.29 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.057B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.586B | 32.58 |
| BellRing Brands (BRBR) | United States | $9.323B | 37.51 |
| Demant (WILYY) | Denmark | $8.735B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.360B | 14.78 |
| ICU Medical (ICUI) | United States | $4.012B | 38.20 |
| Prestige Consumer Healthcare (PBH) | United States | $3.882B | 19.31 |
| Haemonetics (HAE) | United States | $3.691B | 18.01 |
| Envista Holdings (NVST) | United States | $3.413B | 25.42 |
| Perrigo (PRGO) | Ireland | $3.252B | 9.57 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.807B | 18.07 |
| GN Store Nord (GNNDY) | Denmark | $2.585B | 16.58 |
| Neogen (NEOG) | United States | $2.508B | 28.90 |
| LeMaitre Vascular (LMAT) | United States | $2.227B | 54.13 |
| AtriCure (ATRC) | United States | $1.876B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.572B | 27.52 |
| AdaptHealth (AHCO) | United States | $1.416B | 10.11 |
| InMode (INMD) | Israel | $1.410B | 8.48 |
| BioLife Solutions (BLFS) | United States | $1.213B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.205B | 0.00 |
| Owens & Minor (OMI) | United States | $1.124B | 8.78 |
| Curaleaf Holdings (CURLF) | Canada | $0.981B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.843B | 14.87 |
| CeriBell (CBLL) | United States | $0.754B | 0.00 |
| Evolus (EOLS) | United States | $0.666B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.623B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.557B | 24.58 |
| Omeros (OMER) | United States | $0.541B | 0.00 |
| Surmodics (SRDX) | United States | $0.527B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.434B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.434B | 0.00 |
| ZimVie (ZIMV) | United States | $0.394B | 33.23 |
| Valneva SE (VALN) | France | $0.355B | 0.00 |
| Quanterix (QTRX) | United States | $0.342B | 0.00 |
| Cerus (CERS) | United States | $0.332B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.317B | 30.18 |
| Biote (BTMD) | United States | $0.306B | 6.71 |
| Sanara MedTech (SMTI) | United States | $0.285B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.272B | 18.25 |
| High Tide (HITI) | Canada | $0.250B | 103.00 |
| Canopy Growth (CGC) | Canada | $0.237B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.226B | 3.18 |
| Aurora Cannabis (ACB) | Canada | $0.211B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.211B | 14.56 |
| Organigram Holdings (OGI) | Canada | $0.196B | 0.00 |
| Brainsway (BWAY) | Israel | $0.192B | 102.30 |
| MacroGenics (MGNX) | United States | $0.188B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.168B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.149B | 18.77 |
| Veru (VERU) | United States | $0.143B | 0.00 |
| Jin Medical (ZJYL) | China | $0.143B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.130B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 10.87 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| INLIF (INLF) | $0.078B | 0.00 | |
| InterCure (INCR) | Israel | $0.077B | 0.00 |
| Exagen (XGN) | United States | $0.070B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.069B | 35.33 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 14.11 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |